InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,201.07
(
-0.07%
)
Post# of 252302
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rfj1862

Send PM Follow Ignore
Followers 39
Posts 1714
Boards Moderated 0
Alias Born 10/05/2005

rfj1862

Re: None

Tuesday, 03/28/2023 5:42:34 PM

Tuesday, March 28, 2023 5:42:34 PM

Post# of 252302
Well I just dropped some more potentially ill-advised dollars in ARAV

Batrixacept is their only product; it has to be used in combo with other agents where it may restore sensitivity to those agents. Phase 3 data in breast in combo with paclitaxel relatively shortly and BLA in 4Q23 if successful. Also earlier trials for ccRCC and pancreatic, data in the next quarter or so.

Dew I tried to get out of biotech and you sucked me back in
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up